| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 21,947 | |||
| Accounts receivable, net | 19,343 | |||
| Prepaid expenses | 1,399 | |||
| Inventory | 2,477 | |||
| Other current assets | 898 | |||
| Total current assets | 46,064 | |||
| Non-current accounts receivable, net | 2,454 | |||
| Other non-current assets, net of amortization | 743 | |||
| Total non-current assets | 3,197 | |||
| Total assets | 49,261 | |||
| Accounts payable | 5,866 | |||
| Accrued liabilities | 3,701 | |||
| Contract liability - current | 248 | |||
| Total current liabilities | 9,815 | |||
| Term loan | 18,206 | |||
| Pik interest | 1,271 | |||
| Debt discount | 100 | |||
| Contract liability - long-term | 24,561 | |||
| Total long-term liabilities | 43,938 | |||
| Total liabilities | 53,753 | |||
| Common stock, no par value unlimited shares authorized 28,062 shares issued and outstanding (2024 27,527) | 147,652 | |||
| Additional paid-in capital | 71,249 | |||
| Accumulated deficit | -224,636 | |||
| Accumulated other comprehensive income | 1,243 | |||
| Total stockholders' deficit | -4,492 | |||
| Total liabilities and stockholders' deficit | 49,261 | |||
FENNEC PHARMACEUTICALS INC. (FENCF)
FENNEC PHARMACEUTICALS INC. (FENCF)